GlassScriptPhysician profile
Lincoln Shaw
NPI 1003347584
$14,135.48
in general payments reported to CMS, 2019-2025
20 companies · $2,656 in 2025
The $2,656 reported for 2025 was more than what 84% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $887 · 2020: $221 · 2021: $1,235 · 2022: $1,334 · 2023: $5,713 · 2024: $2,091 · 2025: $2,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $5,348 · Food and Beverage: $2,264 · Consulting Fee: $2,084 · Travel and Lodging: $693 · Entertainment: $70.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $5,348.25 |
| Food and Beverage | $2,263.58 |
| Consulting Fee | $2,084.00 |
| Travel and Lodging | $692.66 |
| Entertainment | $70.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $5,212.95 | 2020-2023 | Iluvien |
| Astellas Pharma US INC | $2,876.44 | 2024-2025 | Izervay |
| Apellis Pharmaceuticals, INC. | $1,609.53 | 2023-2024 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $998.95 | 2019-2025 | Eylea, Eylea Hd |
| Allergan, INC. | $854.17 | 2019-2022 | |
| Alcon Vision LLC | $703.99 | 2019-2023 | Clareon, Constellation |
| Eyepoint US, INC. | $367.11 | 2021-2023 | |
| Abbvie INC. | $352.50 | 2022 | |
| Mallinckrodt Hospital Products INC. | $282.09 | 2021-2023 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $248.43 | 2019 | |
| Novartis Pharmaceuticals Corporation | $242.05 | 2019 | |
| Genentech USA, INC. | $115.36 | 2024 | Vabysmo |
| Biogen, INC. | $91.76 | 2022 | |
| Optos, INC. | $70.70 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Ani Pharmaceuticals, INC. | $48.86 | 2025 | Purified Cortrophin Gel |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $22.08 | 2024 | |
| Bausch & Lomb Americas INC. | $17.76 | 2022 | |
| Sight Sciences, INC. | $14.10 | 2020 | |
| New World Medical,INC. | $6.65 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lincoln Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.